Landlocked developing countries (LLDCs) vs Oman: Percentage of bloodstream infection due to Escherichia coli resistant
Landlocked developing countries (LLDCs)
74.2%
in 2022
Oman
78.2%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Oman rank
3rd
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Landlocked developing countries (LLDCs)
- Oman
How they compare
Oman currently reports 78.2% against 74.2% in Landlocked developing countries (LLDCs), a difference of 4.0%.
That makes Oman's figure about 1.1 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 4 times across 6 shared years of data; in 2017 it was Oman ahead.
Landlocked developing countries (LLDCs) ranks 3rd and Oman ranks 3rd of 16 groups.
Across the 2 decades both report, Landlocked developing countries (LLDCs) averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.3% | 52.1% | 19.8% | Oman |
| 2020s | 73.7% | 73.7% | 0.0% | Landlocked developing countries (LLDCs) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Landlocked developing countries (LLDCs) or Oman?
- Oman, at 78.2% against 74.2% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Landlocked developing countries (LLDCs) and Oman?
- 4.0%, with Oman ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Oman?
- 6 years are reported by both, from 2017 to 2022.
- How do Landlocked developing countries (LLDCs) and Oman rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Oman ranks 3rd of 16 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.